4-CN-BINACA-ADB for sale
- 4-CN CUMYL-BINACA
4-cyano CUMYL-BUTINACA (Item No. 20194) is an analytical reference standard that is structurally categorized as a synthetic cannabinoid. The physiological and toxicological properties of this compound are not known. 4-cyano CUMYL-BUTINACA is regulated as a Schedule I compound in the United States. This product is intended for forensic and research applications.
4-CN-BINACA-ADB is intended for research purposes only and is NOT intended for human or animal consumption.
4-CN-BINACA-ADB is a synthetic cannabinoid. It is a member of the indazole family of cannabinoids, specifically an indazole-3-carboxamide type. It is closely related to a series of such compounds developed by Pfizer in 2009. These were originally in development as painkillers. Like most indazole synthetic cannabinoids, this is a powerful CB1 agonist. There is little formal data available, but anecdotal evidence suggests an active dose as low as 1/10th of a milligram.
4-CN-BINACA-ADB Approved Use
Note that 4-CN-BINACA-ADB is not approved as a drug, treatment or supplement in any known jurisdiction. It is offered purely as a research chemical, and should never be taken by humans, or used for any kind of in vivo chemical research. It is sold for in vitro experimentation or for sample calibration purposes only.
Is there a history of misuse?
Unfortunately, yes. Chemicals including 4-CN-BINACA-ADB have been detected in a called synthetic cannabis blends around the world, beginning with detection in Japan in 2015. These detections are related to a range of hospitalisations of users, but it is unclear which synthetic chemical led to the illness or injury.
Is 4-CN-BINACA-ADB legal in my country?
It is not currently known to be illegal in any major jurisdictions.
As the importer, it is your responsibility to research and understand the laws and policies of your country. You bear the responsibility for this, and the risk of any shipments seized or destroyed for non-compliance with local policy or law.